Answers are grounded in this paper and cite their sources.
Background Diagnostic delays in laryngotracheal stenosis (LTS) are common due to non-specific symptoms and reliance on invasive laryngotracheobronchoscopy (LTB). The comparative accuracy and optimal clinical roles of non-invasive alternatives—spirometry, computed tomography (CT), and CT virtual bronchoscopy (CTVB)—remain undefined, particularly for resource-limited settings. Methods This diagnostic meta-analysis was conducted according to a pre-registered protocol (PROSPERO CRD420251044416) and followed PRISMA-DTA guidelines. Data from 14 studies (30 evaluations) were pooled to compare the accuracy of spirometry, CT, and CTVB for diagnosing adolescent/adult LTS, using LTB as the reference standard. Pooled sensitivity, specificity, likelihood ratios, and diagnostic odds ratios were calculated using bivariate random-effects models. Meta-regression explored heterogeneity sources (PROGRESS-Plus framework), and the GRADE-Equity approach assessed evidence certainty. Results CTVB demonstrated the highest sensitivity (93·7%, 95% CI: 90·8–95·9) and optimal rule-out capacity (NLR 0·14). CT showed the highest specificity (97·1%, 94·9–98·5) and rule-in utility (PLR 9·7). Spirometry offered balanced accuracy (sensitivity 91·3%; specificity 90·1%) but with significant heterogeneity; its accuracy declined with increasing patient age ( p < 0·05). Meta-regression identified key modifiers: retrospective design reduced CT sensitivity, and site-based (vs. diameter) CTVB measurement reduced specificity. Equity analysis revealed high-risk groups, including older adults for spirometry and populations in resource-limited settings for CT. Conclusions This analysis defines the complementary roles of CTVB and CT as the optimal non-invasive screening-confirmation duo for LTS. The proposed CTVB→CT diagnostic pathway can fundamentally shift the diagnostic paradigm, reducing the need for invasive endoscopy as a first-line test. Implementation of this strategy, particularly with standardized CTVB measurements and age-adjusted spirometry thresholds, can mitigate diagnostic delays and improve equity in patient care globally.
No takes yet. Share an insight, caveat, or question.
Klopper et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: